Cleared Traditional

K082588 - GAMMALOC SYSTEM, MODEL 03-00001 (FDA 510(k) Clearance)

Class I Radiology device.

K082588 · Dilon Technologies, LLC · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2009
Decision
459d
Days
Class 1
Risk

K082588 is an FDA 510(k) clearance for the GAMMALOC SYSTEM, MODEL 03-00001. Classified as Camera, Scintillation (gamma) (product code IYX), Class I - General Controls.

Submitted by Dilon Technologies, LLC (Newport News, US). The FDA issued a Cleared decision on December 11, 2009 after a review of 459 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1100 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Radiology submissions.

View all Dilon Technologies, LLC devices

Submission Details

510(k) Number K082588 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 08, 2008
Decision Date December 11, 2009
Days to Decision 459 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
352d slower than avg
Panel avg: 107d · This submission: 459d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code IYX Camera, Scintillation (gamma)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 892.1100
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.